Clinical Trials Sponsored by SESEP
Total 7 results
-
Sesen Bio, Inc.TerminatedNeoplasms, Glandular and EpithelialRussian Federation, Georgia
-
Sesen Bio, Inc.CompletedBladder CancerUnited States, Canada
-
Sesen Bio, Inc.TerminatedHead and Neck Cancer | Head and Neck Neoplasms | Carcinoma, Squamous Cell | Squamous Cell Carcinoma of the Head and Neck | Neoplasms, Squamous Cell | Mouth NeoplasmsUnited States, Canada
-
Sesen Bio, Inc.CompletedUrinary Bladder Cancer | Bladder Cancer | Bladder Neoplasms | Bladder TumorsUnited States, Canada
-
Sesen Bio, Inc.TerminatedHead and Neck Cancer | Head and Neck Neoplasms | Carcinoma, Squamous Cell | Neoplasms, Squamous Cell | Mouth Neoplasms | Carcinoma, Squamous Cell of Head and NeckSpain, Germany, Israel, Italy, Poland, United Kingdom, India, Argentina, France, Hungary, Serbia, Croatia, Ukraine, Brazil, Russian Federation, Mexico, Romania, Slovakia
-
Fondation Paralysie CérébraleKappa Santé; Envoludia; FFAIMC; CNSA; KLESIA; Fondation L'Oréal; SESEPCompleted
-
University Hospital, Clermont-FerrandMedDay Pharmaceuticals SA; OFSEP (Observatoire Français de la Sclérose en Plaques) and other collaboratorsUnknownProgressive Multiple SclerosisFrance